In the relentless battle against cancer, understanding how malignant cells endure and adapt within their hostile microenvironments remains a paramount challenge. One such critical stressor in tumors is the scarcity of glucose, a vital nutrient consumed voraciously by cancer cells to fuel their unchecked growth and proliferation. A groundbreaking study led by a team from the Institute for Glyco-core Research (iGCORE) at Nagoya University sheds new light on the molecular underpinnings that allow cancer cells to survive glucose deprivation. Their findings unravel the enigmatic role of the mannose metabolic pathway as a sensor and regulator of cell fate under glucose-starved conditions, offering tantalizing prospects for targeted cancer therapeutics.
Cancer cells are notorious for their metabolic reprogramming, rapidly consuming glucose to sustain energy production and biosynthetic processes. However, this frenzied consumption creates a glucose-poor microenvironment, pressuring tumor cells to invoke adaptive survival mechanisms. Traditionally, research has focused on how glycolysis and associated pathways adjust in this context. Yet, the mannose pathway—responsible for synthesizing mannose sugars and incorporating them into complex glycans—has remained a relatively uncharted domain, primarily due to the intertwined nature of its metabolism with glucose processing and the technical complexities this poses.
The mannose pathway’s significance lies in its contribution to N-glycosylation, an essential post-translational modification where mannose residues are attached to proteins, influencing their folding, stability, and signaling functions. Defects in this glycosylation can drastically alter cellular homeostasis and fate. The research team employed a sophisticated genetic engineering approach to decouple the mannose pathway from glycolysis, enabling them to manipulate mannose flux independently of glucose levels. This strategy allowed a precise dissection of how varying mannose availability impacts cell survival and signaling networks when glucose is limited.
Their experiments revealed a critical threshold of mannose pathway activity that dictates cell fate. A moderate reduction in mannose metabolism impaired N-glycan biosynthesis, triggering adaptive pro-survival signaling within the endoplasmic reticulum (ER), the cellular organelle responsible for protein folding and transport. Remarkably, these stress responses were initiated without compromising immediate cell viability, suggesting a finely tuned balance between metabolic flux and cellular adaptation.
When mannose pathway activity was further diminished to minimal levels that still permitted survival, the researchers observed a depletion of the lysosomal glycocalyx—a protective glycan-rich layer cushioning lysosomal membranes. Given that lysosomes play a pivotal role as the cell’s recycling centers, maintaining their integrity is paramount. The loss of glycocalyx exposed lysosomal membranes to destabilization, which markedly increased the risk of lysosomal rupture and consequential cell death, highlighting a vulnerable node in cancer cell metabolism during glucose scarcity.
Mechanistically, the team demonstrated that the low metabolic flow of glucose into the mannose pathway precipitated these cellular alterations through defects in N-glycosylation processes. This cascade effect underscores the mannose pathway’s pivotal role as a metabolic sensor, linking nutrient availability to quality control and survival signaling machinery. The activated pro-survival pathways in the ER serve as an adaptive lifeline, enabling cancer cells to endure and thrive amidst nutrient stress.
Professor Yoichiro Harada, the study’s senior author, emphasized the significance of these insights: “Our findings illustrate that cancer cells exploit reduced glucose utilization in N-glycan biosynthesis to activate crucial pro-survival signaling. This fundamentally broadens our understanding of metabolic adaptations in tumors and opens new avenues for intervention.”
The implications of this study extend far beyond basic science. Therapeutically targeting the mannose pathway or its downstream survival mechanisms could sensitize cancer cells to glucose deprivation, enhancing the efficacy of metabolic inhibitors or conventional chemotherapies. Since most solid tumors experience fluctuating nutrient supplies, exploiting this metabolic vulnerability holds promise for overcoming resistance and relapse.
Future research will be directed towards unraveling the precise molecular effectors orchestrating these adaptive responses and identifying small molecules capable of disrupting pro-survival signals without harming normal cells. The research team is optimistic that integrating mannose pathway modulation into cancer treatment regimens could represent a paradigm shift in oncology.
This study, published in the Journal of Biological Chemistry on January 28, 2026, represents a collaborative effort involving experts from Osaka International Cancer Institute, The University of Osaka, RIKEN Center for Sustainable Resource Science, and Nagoya University. It was supported by reputable funding bodies including the Takeda Science Foundation, JSPS KAKENHI, and the Mizutani Foundation for Glycosciences, underscoring the scientific community’s commitment to advancing cancer metabolism research.
In summary, the mannose metabolic pathway emerges not merely as a static biosynthetic route but as a dynamic sensor and regulator of cell fate under metabolic stress. By interlinking glucose availability with critical glycosylation processes and stress signaling, it equips cancer cells with the necessary tools to navigate the nutrient-scarce tumor microenvironment. Targeting this metabolic nexus offers a promising frontier in the quest for more effective and selective cancer therapies.
Subject of Research: Cells
Article Title: Mannose metabolic pathway senses glucose supply and regulates cell fate decisions
News Publication Date: 28-Jan-2026
Web References: DOI: 10.1016/j.jbc.2026.111213
Image Credits: Yoichiro Harada, Institute for Glyco-core Research (iGCORE), Nagoya University
Keywords: Health and medicine, Cancer, Biochemistry, Glycobiology, Metabolism, Cell biology, Cell fate regulation, Regulatory mechanisms, Signaling pathways, Hypothesis driven research
